Clorox Co. (CLX) Misses Q4 EPS by 5c; Reaffirms FY EPS

Clorox Co. (NYSE: CLX) reported Q4 EPS of $1.30, $0.05 worse than the analyst estimate of $1.35. Revenue for the quarter came in at $1.51 billion versus the consensus estimate of $1.52 billion.

Clorox Co. reaffirmed FY2014 EPS of $4.35-$4.50, versus the consensus of $4.32. Sales about flat (1% to 3% increase, currency neutral). 25 basis points to 50 basis points of EBIT margin expansion.

"Our fiscal year 2014 results reflect the challenges we faced throughout the year, including unfavorable currency exchange rates across multiple markets, sluggish categories and heightened competitive activity," said Chairman and CEO Don Knauss. "In the fourth quarter, we stepped up our plans to address these challenges, including investing in incremental demand-building programs to reinforce the value proposition of our brands, reinvigorate our categories and profitably grow market shares."

For earnings history and earnings-related data on Clorox Co. (CLX) click here.

You May Also Be Interested In

• Bank of America (BAC) Tops Q1 EPS by $0.07, Beats on Revenue
• UnitedHealth Group (UNH) Tops Q1 EPS by 29c, Tops on Revenue; Offers FY24 EPS Guidance
• Commerce Bancshares (CBSH) Tops Q1 EPS by 5c